In an immune-induced mouse model of IBD, specific inhibition of the FKBP family in intestinal tissue significantly reduced MLCK1 recruitment, phosphorylated MLC levels, intestinal permeability, and CD3+ T cell levels in the intestinal epithelium, without affecting TNF-α and IFN-γ levels [115]. Here, MYLK is linked to inflammatory bowel disease.